EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $14,824,000 | -13.4% | 213,822 | -5.5% | 0.04% | -11.9% |
| Q2 2018 | $17,124,000 | -35.1% | 226,333 | -54.8% | 0.04% | -36.4% |
| Q1 2018 | $26,394,000 | -17.9% | 500,922 | -16.7% | 0.07% | -13.2% |
| Q4 2017 | $32,132,000 | -10.4% | 601,505 | 0.0% | 0.08% | -5.0% |
| Q3 2017 | $35,874,000 | -30.2% | 601,505 | -7.7% | 0.08% | -35.0% |
| Q2 2017 | $51,397,000 | -6.3% | 651,505 | -1.4% | 0.12% | -8.9% |
| Q1 2017 | $54,824,000 | +8.9% | 661,005 | +4.1% | 0.14% | +5.5% |
| Q4 2016 | $50,365,000 | +26.6% | 634,805 | +11.7% | 0.13% | +28.0% |
| Q3 2016 | $39,774,000 | – | 568,205 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |